CLDX Stock Analysis: Buy, Sell, or Hold?
CLDX - Celldex Therapeutics, Inc
$29.35
-0.25 (-0.84%)
▼
5d:
-1.41%
30d:
-9.08%
90d:
-6.02%
HOLD
MODERATE Confidence
Analysis Updated: Jun 10, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When CLDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CLDX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CLDX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CLDX is currently trading at $29.35, which is considered oversold relative to its 30-day fair value range of $29.57 to $32.79.
Technical Outlook: Technically, CLDX is in a strong uptrend. Immediate support is located at $28.38, while resistance sits at $32.30.
Market Sentiment: CLDX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $58.43 (+99.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CLDX is in a strong uptrend. Immediate support is located at $28.38, while resistance sits at $32.30.
Market Sentiment: CLDX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $58.43 (+99.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$29.57 -
$32.79
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 99.1% below Wall St target ($58.43)
Trading Range Analysis
30-Day Trading Range
$29.57 -
$32.79
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$28.38
Resistance Level
$32.30
Current Trend
Strong Uptrend
Technical data as of
Jun 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.45
Wall Street Target
$58.43
(+99.1%)
Revenue Growth (YoY)
-97.8%
Share & Embed Analysis
Last updated: June 10, 2026 11:47 PM ET
Data refreshes hourly during market hours. Next update: 12:47 AM
Data refreshes hourly during market hours. Next update: 12:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 53 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$253 | 56 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$118 | 49 HOLD |
